Skip to main content

Advertisement

SpringerLink
Log in

OCT4 pseudogenes present in human leukemia cells

  • Original Article
  • Published:
Clinical and Experimental Medicine Aims and scope Submit manuscript

Abstract

The transcription factor OCT4 is expressed in embryonic stem cells (ESCs) and has been considered as a main regulator in maintaining pluripotency of ESCs. Several studies have showed OCT4 expression in human solid tumor and adult stem or progenitor cells. However, whether OCT4 is expressed in normal hematopoietic system including the peripheral blood and bone marrow remains controversial. Furthermore, the functional expression of OCT4 in leukemia cells and its potential significance in leukemia studies have been poorly defined. The aim of this study was to examine and analyze the genuine expression of OCT4 in human leukemia cells by means of RT-PCR, flow cytometry, PCR product sequencing and alignment with NCBI BLAST and DNAMAN software. The full lengths of the putative OCT4 genes were amplified in 2/9 leukemia cell lines and 7/49 leukemia patients’ samples. However, many base mutations in putative OCT4 positive samples were found. Sequence alignment analysis showed a higher similarity between the putative OCT4 PCR products and the pseudogenes in chromosomes 1 and 8. The positive rates of OCT4 protein detected with flow cytometry were low, and almost all of them were less than 10% of positivity. A very small fraction of leukemia stem cells with OCT4 protein expression was found. We conclude that OCT4 pseudogenes in chromosomes 1 and 8 present in the panel of leukemia cells tested and the OCT4 protein is rarely detected with flow cytometry in leukemia cells.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Witte KE, Ahlers J, Schäfer I et al (2011) High proportion of leukemic stem cells at diagnosis is correlated with unfavorable prognosis in childhood acute myeloid leukemia. Pediatr Hematol Oncol 28:91–99

    Article  PubMed  CAS  Google Scholar 

  2. van Rhenen A, Feller N, Kelder A et al (2005) High stem cell frequency in acute myeloid leukemia at diagnosis predicts high minimal residual disease and poor survival. Clin Cancer Res 11:6520–6527

    Article  PubMed  Google Scholar 

  3. Ferrando AA, Neuberg DS, Staunton J et al (2002) Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia. Cancer Cell 1:75–87

    Article  PubMed  CAS  Google Scholar 

  4. Yamazaki H, Wilson Xu C, Naito M et al (2011) Regulation of cancer stem cell properties by CD9 in human B-acute lymphoblastic leukemia. Biochem Biophys Res Commun 409:14–21

    Article  PubMed  CAS  Google Scholar 

  5. Rosner MH, Vigano MA, Ozato K, Timmons PM et al (1990) A POU-domain transcription factor in early stem cells and germ cells of the mammalian embryo. Nature 345:686–692

    Article  PubMed  CAS  Google Scholar 

  6. Cheng L, Sung MT, Cossu-Rocca P et al (2007) OCT4: biological functions and clinical applications as a marker of germ cell neoplasia. J Pathol 211:1–9

    Article  PubMed  CAS  Google Scholar 

  7. Atlasi Y, Mowla SJ, Ziaee SA, Bahrami AR (2007) OCT-4, an embryonic stem cell marker, is highly expressed in bladder cancer. Int J Cancer 120:1598–1602

    Article  PubMed  CAS  Google Scholar 

  8. Ezeh UI, Turek PJ, Reijo RA, Clark AT (2005) Human embryonic stem cell genes OCT4, NANOG, STELLAR, and GDF3 are expressed in both seminoma and breast carcinoma. Cancer 104:2255–2265

    Article  PubMed  CAS  Google Scholar 

  9. Iki K, Pour PM (2006) Expression of Oct4, a stem cell marker, in the hamster pancreatic cancer model. Pancreatology 6:406–413

    Article  PubMed  CAS  Google Scholar 

  10. Chen Z, Xu WR, Qian H et al (2009) Oct4, a novel marker for human gastric cancer. J Surg Oncol 9:414–419

    Article  Google Scholar 

  11. Jiang Y, Jahagirdar BN, Reinhardt RL et al (2002) Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418:41–49

    Article  PubMed  CAS  Google Scholar 

  12. Kucia M, Reca R, Campbell FR et al (2006) A population of very small embryonic-like (VSEL) CXCR4(+)SSEA-1(+)Oct-4+ stem cells identified in adult bone marrow. Leukemia 20:857–869

    Article  PubMed  CAS  Google Scholar 

  13. Pochampally RR, Smith JR, Ylostalo J et al (2004) Serum deprivation of human marrow stromal cells (hMSCs) selects for a sub-population of early progenitor cells with enhanced expression of Oct-4 and other embryonic genes. Blood 103:1647–1652

    Article  PubMed  CAS  Google Scholar 

  14. D’Ippolito G, Diabira S, Howard GA et al (2004) Marrow-isolated adult multilineage inducible (MIAMI) cells, a unique population of postnatal young and old human cells with extensive expansion and differentiation potential. J Cell Sci 117:2971–2981

    Article  PubMed  Google Scholar 

  15. Baal N, Reisinger K, Jahr H et al (2004) Expression of the transcription factor Oct-4 and other embryonic genes in CD133 positive cells from human umbilical cord blood. Thromb Haemost 92:767–775

    PubMed  CAS  Google Scholar 

  16. Takeda J, Seino S, Bell GI (1992) Human Oct3 gene family: cDNA sequences, alternative splicing, gene organization, chromosomal location, and expression at low levels in adult tissues. Nucleic Acids Res 20:4613–4620

    Article  PubMed  CAS  Google Scholar 

  17. Mueller T, Luetzkendorf J, Nerger K, Schmoll HJ, Mueller LP (2009) Analysis of OCT4 expression in an extended panel of human tumor cell lines from multiple entities and in human mesenchymal stem cells. Cell Mol Life Sci 66:495–503

    Article  PubMed  CAS  Google Scholar 

  18. Cauffman G, Liebaers I, Van Steirteghem A, Van de Velde H (2006) POU5F1 isoforms show different expression patterns in human embryonic stem cells and preimplantation embryos. Stem Cells 24:2685–2691

    Article  PubMed  CAS  Google Scholar 

  19. Atlasi Y, Mowla SJ, Ziaee SA, Gokhale PJ, Andrews PW (2008) OCT4 spliced variants are differentially expressed in human pluripotent and nonpluripotent cells. Stem Cells 26:3068–3074

    Article  PubMed  CAS  Google Scholar 

  20. Wang X, Dai J (2010) Concise review: isoforms of OCT4 Contribute to the confusing diversity in stem cell biology. Stem Cells 28:885–893

    Article  PubMed  CAS  Google Scholar 

  21. Liedtke S, Enczmann J, Waclawczyk S, Wernet P, Kögler G (2007) Oct4 and its pseudogenes confuse stem cell research. Cell Stem Cell 11:364–366

    Article  Google Scholar 

  22. Redshaw Z, Strain AJ (2010) Human haematopoietic stem cells express Oct4 pseudogenes and lack the ability to initiate Oct4 promoter-driven gene expression. J Negat Results Biomed 31:2

    Article  Google Scholar 

  23. Suo G, Han J, Wang X, Zhang J et al (2005) Oct4 pseudogenes are transcribed in cancers. Biochem Biophys Res Commun 337:1047–1051

    Article  PubMed  CAS  Google Scholar 

  24. Schoenhals M, Kassambara A, De Vos J et al (2009) Embryonic stem cell markers expression in cancers. Biochem Biophys Res Commun 383:157–162

    Article  PubMed  CAS  Google Scholar 

  25. Gaussmann A, Wenger T, Eberle I et al (2007) Combined effects of the two reciprocal t(4;11) fusion proteins MLL-AF4 and AF4-MLL confer resistance to apoptosis, cell cycling capacity and growth transformation. Oncogene 26:3352–3363

    Article  PubMed  CAS  Google Scholar 

  26. Cantz T, Key G, Bleidissel M, Gentile L et al (2008) Absence of OCT4 expression in somatic tumor cell lines. Stem Cells 26:692–697

    Article  PubMed  CAS  Google Scholar 

  27. Wilson K, Case M, Minto L et al (2010) Flow minimal residual disease monitoring of candidate leukemic stem cells defined by the immunophenotype, CD34+ CD38lowCD19+ in B-lineage childhoood acute lymphoblastic leukemia. Haematologica 95:679–683

    Article  PubMed  Google Scholar 

  28. van Rhenen A, Moshaver B, Kelder A et al (2007) Aberrant marker expression patterns on the CD34+ CD38− stem cell compartment in acute myeloid leukemia allows to distinguish the malignant from the normal stem cell compartment both at diagnosis and in remission. Leukemia 21:1700–1707

    Article  PubMed  Google Scholar 

  29. van Rhenen A, van Dongen GA, Kelder A et al (2007) The novel AML stem cell associated antigen CLL-1 aids in discrimination between normal and leukemic stem cells. Blood 110:2659–2666

    Article  PubMed  Google Scholar 

  30. Takahashi K, Tanabe K, Ohnuki M et al (2007) Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131:861–872

    Article  PubMed  CAS  Google Scholar 

  31. Park IH, Zhao R, West JA et al (2008) Reprogramming of human somatic cells to pluripotency with defined factors. Nature 451:141–146

    Article  PubMed  CAS  Google Scholar 

  32. Eberle I, Pless B, Braun M et al (2010) Transcriptional properties of human NANOG1 and NANOG2 in acute leukemic cells. Nucleic Acids Res 38:5384–5395

    Article  PubMed  CAS  Google Scholar 

  33. Burger AM (2009) Targeting leukemic stem cells. In: Bagley RG, Teicher BA (eds) Stem cells and cancer, Humana Press, New York, pp 263–273

  34. Lu C, Hassan HT (2006) Human stem cell factor-antibody [anti-SCF] enhances chemotherapy cytotoxicity in human CD34+ resistant myeloid leukaemia cells. Leuk Res 30:296–302

    Article  PubMed  CAS  Google Scholar 

  35. Bonnet D, Dick JE (1997) Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 3:730–737

    Article  PubMed  CAS  Google Scholar 

  36. Zangrossi S, Marabese M, Broggini M et al (2007) Oct-4 expression in adult human differentiated cells challenges its role as a pure stem cell marker. Stem Cells 25:1675–1680

    Article  PubMed  CAS  Google Scholar 

  37. Wang L, O’Leary H, Fortney J et al (2007) Ph+/VE-cadherin+ identifies a stem cell like population of acute lymphoblastic leukemia sustained by bone marrow niche cells. Blood 110:3334–3344

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This study was supported in part by grants from the National Natural Science Fundation of China (No: 30971283), the Zhejiang Provincial Natural Science Fundation of China (No: Z205166), and the Zhejiang Provincial Fund of Science and Technology Bureau (No: 2007C23007). The authors would also like to thank Mr Hongqiang Shen, Mrs Baiqin Qian, and Mr Ning Zhao for their help on the FCM technology.

Conflict of interest

None.

Author information

Authors and Affiliations

  1. Division of Hematology-oncology, Children’s Hospital of Zhejiang University School of Medicine, #57 Zhuganxiang Road, Yan-an Street, Hangzhou, 310003, People’s Republic of China

    Xiaoping Guo & Yongmin Tang

Authors
  1. Xiaoping Guo
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yongmin Tang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yongmin Tang.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Guo, X., Tang, Y. OCT4 pseudogenes present in human leukemia cells. Clin Exp Med 12, 207–216 (2012). https://doi.org/10.1007/s10238-011-0163-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10238-011-0163-4

Keywords

Search

Navigation